VYGR
VYGR
NASDAQ · Biotechnology

Voyager Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.50
-0.08 (-2.23%)
As of Jun 30, 10:24 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,226.9% upside
Low Target $29.94
Average Target $46.44
High Target $64.67
Current Price $3.50
Current
$3.50
Target
$46.44
$29.94 $46.44 avg $64.67
Scenario Analysis
Bear Case
$29.94
755.4%
Low target
Base Case
$46.44
+1,226.9%
Avg target
Bull Case
$64.67
+1,747.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.55
-36.9% from high
52-Week Low
$2.83
+23.7% from low
Target vs 52W High
$46.44
+736.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%